Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Other Non Operating Income (2016 - 2025)

Surgery Partners (SGRY) has disclosed Other Non Operating Income for 11 consecutive years, with -$1.3 million as the latest value for Q3 2025.

  • Quarterly Other Non Operating Income changed N/A to -$1.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.3 million through Dec 2025, up 93.69% year-over-year, with the annual reading at -$1.3 million for FY2025, 74.51% up from the prior year.
  • Other Non Operating Income hit -$1.3 million in Q3 2025 for Surgery Partners, up from -$5.1 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $500000.0 in Q3 2021 to a low of -$15.5 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged -$7.5 million across 5 years, with a median of -$7.4 million in 2021.
  • Biggest YoY gain for Other Non Operating Income was 11.51% in 2023; the steepest drop was 11.51% in 2023.
  • Year by year, Other Non Operating Income stood at $500000.0 in 2021, then crashed by 2880.0% to -$13.9 million in 2022, then fell by 11.51% to -$15.5 million in 2023, then surged by 67.1% to -$5.1 million in 2024, then skyrocketed by 74.51% to -$1.3 million in 2025.
  • Business Quant data shows Other Non Operating Income for SGRY at -$1.3 million in Q3 2025, -$5.1 million in Q2 2024, and -$15.5 million in Q4 2023.